Ledger.Open graph →
SEC Form D · Amendment · filed December 10, 2018

RELMADA THERAPEUTICS, INC

Offering
$10.0M
Sold
$5.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Sergio Traversa · New York, NYExec · DirectorPaul Kelly · New York, NYDirectorOttavio Vitolo · New York, NYExecMaged Shenouda · New York, NYDirectorCharles Casamento · New York, NYDirectorKieran Snyder · Seattle, WAExecJoseph Esteves · East Brunswick, NJDirectorInvestments Minetta · Brooklyn, NYDirectorJohn King · East Brunswick, NJExec · DirectorLynn Perry · Atlanta, GADirectorRichard R. Gray · Coppell, TXExec · DirectorKevin R. Westfall · Coppell, TXDirectorDenmar R. Dixon · Coppell, TXDirectorJoseph R. Reece · Coppell, TXDirectorKaren A. Nista · West Hartford, CTExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗